Who is a Good Candidate for DURYSTA?

Posted: Apr 05, 2021 by The Eye Center
Filed under: DURYSTA, gluacoma

What is DURYSTA?

There are some glaucoma patients who have trouble using the eye drops meant to control their intraocular pressure. They may have difficulty properly administering their eye drops daily due to arthritis, itchy or irritated eyes, or the complications associated with memory disorders such as dementia.

For patients undergoing glaucoma treatment in Columbia, DURYSTA offers a long-term alternative to topical eye drops. It’s the first sustained-release implant of common glaucoma medication meant to reduce IOP in patients with either open-angle glaucoma or ocular hypertension. It lasts six months to one year in most patients and is painlessly inserted into the eye in a minute-long procedure at a Columbia, SC eye clinic.

DURYSTA Provides an Alternative Treatment for Glaucoma Patients

If patients don’t properly use the eye drops prescribed to them by their doctor at The Eye Center in Columbia, they have a much higher risk of experiencing vision loss in the future. Thankfully, DURYSTA provides a long-term solution for patients who struggle with daily eye drops.

DURYSTA is preservative-free and biodegrades over time, meaning there’s never any need to return to your ophthalmologist in Columbia, SC, to get the implant removed. DURYSTA gives patients who have trouble using their eye drops an alternative way to control the pressure in their eyes and gives their doctors peace of mind.

It should be noted that DURYSTA is not suitable for anyone with Fuch’s Dystrophy, aphakia, a history of corneal transplant, or a hypersensitivity to bimatoprost.

To learn if you are a suitable candidate for DURYSTA, talk to your ophthalmologist at The Eye Center in Columbia, SC.

 Spotlight

TECNIS® Symfony IOL
The first and only presbyopia-correcting extended range of vision IOL.
TECNIS® Symfony IOL
button_learnmore

Glaucoma & iStent
iStent works to help control your eye pressure by improving the outflow of fluid from your eyes.
iStent
button_learnmore

Diabetic Eye Disease
Diabetic eye disease is the leading cause of blindness in the 20-64 year age group.
Diabetic Retinopathy
button_learnmore

LenSx® Femtosecond Laser
The LenSx® Laser is the first femtosecond laser cleared by the FDA for use in cataract surgery.
LenSx® Femtosecond Laser
button_learnmore